Essential hypertension is an important cause of cardiovascular morbidity and mortality worldwide
with significant clinical and economic implications. The field of antihypertensive treatment already numbers
numerous agents and classes of drugs. However, patients are still developing uncontrolled hypertension. Hence
there is a continuous need for novel agents with good tolerability. Advances in this field are focusing both on
pharmacotherapy, with the developments in traditional and non-traditional targets, as well as interventional
techniques such as renal denervation and baroreflex activation therapy. It is likely that future strategies may involve
a tailored approach to the individual patient, with genetic modulation playing a key role.
Keywords: Hypertension, therapy, drug, intervention, novel, blood pressure.
Rights & PermissionsPrintExport